Pharmexa A/S
8Patents
0Active
8Granted
27Portfolio score
Filing activity: Apr 15, 1998 → Feb 19, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7097837B2 | Synthetic vaccine agents | Chemistry; Metallurgy | 33 | Expired |
| US7135181B2 | Method for down-regulation of amyloid | Emerging Cross-Sectional Technologies | 26 | Expired |
| US7005498B1 | Methods for therapeutic vaccination | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7070784B1 | Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues | Chemistry; Metallurgy | 21 | Expired |
| US7056512B1 | Method for down-regulating GDF-8 activity | Chemistry; Metallurgy | 6 | Expired |
| US7118750B1 | Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7285273B1 | Method for down-regulating IL5 activity | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6746669B1 | Method for down-regulating IL5 activity | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.